Skip to main content

Table 4 Schematic description of clinical outcomes according to MIC, genotype, age, Charlson comorbidity index (CCI), presence of concomitant bacteremia and septic shock in cefepime, piperacillin/tazobactam and ertapenem groups

From: Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

Case

MIC (μg/mL)

ESBLs genotype

CCI

Bacteremia

Septic shock

Clinical outcome

A. Cefepime (N = 6)

 Patient 1

2

CTX-M-14

5

No

No

Success

 Patient 2

2

CTX-M-14

3

No

No

Success

 Patient 3

1

CTX-M-14

4

No

No

Failure

 Patient 4

2

CTX-M-14

6

No

No

Failure

 Patient 5

1

SHV-12

5

No

Yes

Failure and expired

 Patient 6

2

CTX-M-14

5

No

Yes

Failure and expired

B. Piperacillin/tazobactam (N = 33)

 Patient 1

4

CTX-M-14

6

No

No

Success

 Patient 2

4

CTX-M-15

5

No

Yes

Success

 Patient 3

4

CTX-M-15

0

No

No

Success

 Patient 4

4

CTX-M-15

1

No

No

Success

 Patient 5

4

CTX-M-27

9

No

No

Success

 Patient 6

4

CTX-M-27

9

No

No

Success

 Patient 7

4

CTX-M-27

9

No

No

Success

 Patient 8

8

CTX-M-14

3

Yes

Yes

Success

 Patient 9

8

CTX-M-14

1

No

No

Success

 Patient 10

16

CTX-M-1

4

No

No

Success

 Patient 11

16

CTX-M-3

2

No

Yes

Success

 Patient 12

16

CTX-M-14

3

No

No

Success

 Patient 13

16

CTX-M-14

3

Yes

Yes

Success

 Patient 14

16

CTX-M-15

1

No

Yes

Success

 Patient 15

16

CTX-M-15

4

No

No

Success

 Patient 16

16

CTX-M-27

0

No

No

Success

 Patient 17

16

CTX-M-15

3

No

No

Success

 Patient 18

16

CTX-M-14

5

No

No

Success

 Patient 19

16

CTX-M-14

7

No

No

Success

 Patient 20

16

CTX-M-14

1

Yes

No

Success

 Patient 21

16

CTX-M-14

8

No

No

Success

 Patient 22

16

Not tested

5

No

No

Success

 Patient 23

16

Not tested

2

No

Yes

Success

 Patient 24

16

Not tested

7

No

No

Success

 Patient 25

16

Not tested

3

No

No

Success

 Patient 26

16

Not tested

7

No

No

Success

 Patient 27

16

Not tested

8

No

No

Success

 Patient 28

16

Not tested

5

No

No

Success

 Patient 29

16

Not tested

5

No

No

Success

 Patient 30

16

Not tested

3

Yes

No

Success

 Patient 31

16

Not tested

7

Yes

Yes

Success

 Patient 32

16

CTX-M-15

9

Yes

Yes

Failure and expired

 Patient 33

16

CTX-M-27

10

No

Yes

Failure and expired

C. Ertapenem (N = 33)

 Patient 1

0.5

CTX-M-15

0

No

No

Success

 Patient 2

0.5

CTX-M-27

0

No

No

Success

 Patient 3

0.5

CTX-M-14

1

No

No

Success

 Patient 4

0.5

CTX-M-15

1

No

No

Success

 Patient 5

0.5

CTX-M-14

1

Yes

No

Success

 Patient 6

0.5

CTX-M-15

1

No

Yes

Success

 Patient 7

0.5

CTX-M-3

2

No

Yes

Success

 Patient 8

0.5

CTX-M-14

2

Yes

Yes

Success

 Patient 9

0.5

CTX-M-14

3

No

No

Success

 Patient 10

0.5

CTX-M-15

3

No

No

Success

 Patient 11

0.5

CTX-M-15

3

No

No

Success

 Patient 12

0.5

CTX-M-14

3

Yes

No

Success

 Patient 13

0.5

CTX-M-14

3

Yes

Yes

Success

 Patient 14

0.5

CTX-M-14

3

Yes

Yes

Success

 Patient 15

0.5

CTX-M-1

4

No

No

Success

 Patient 16

0.5

CTX-M-15

4

No

No

Success

 Patient 17

0.5

CTX-M-14

5

No

No

Success

 Patient 18

0.5

CTX-M-14

5

No

No

Success

 Patient 19

0.5

CTX-M-15

5

No

No

Success

 Patient 20

0.5

CTX-M-14

5

Yes

No

Success

 Patient 23

0.5

CTX-M-15

5

No

Yes

Success

 Patient 21

0.5

CTX-M-14

6

Yes

No

Success

 Patient 22

0.5

CTX-M-14

7

No

No

Success

 Patient 24

0.5

CTX-M-14

7

No

No

Success

 Patient 25

0.5

CTX-M-14

7

No

No

Success

 Patient 26

0.5

CTX-M-14

8

No

No

Success

 Patient 27

0.5

CTX-M-14

8

No

No

Success

 Patient 28

0.5

CTX-M-27

9

No

No

Success

 Patient 29

0.5

CTX-M-27

9

No

No

Success

 Patient 30

0.5

CTX-M-27

9

No

No

Success

 Patient 31

0.5

CTX-M-27

10

No

No

Success

 Patient 32

0.5

CTX-M-14

9

Yes

Yes

Failure and expired

 Patient 33

0.5

CTX-M-15

7

Yes

Yes

Failure and expired

  1. Not tested: The isolate was ESBLs-positive by Vitek-2 system but not tested the ESBLs genotyping due to loss of the isolate